Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570726 · ClinicalTrials.gov registry record · Phase 1
Treatment of Failing Blebs With Ranibizumab
A Phase 1 study, sponsored by The New York Eye & Ear Infirmary.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00570726: Completed Phase 1 study, sponsored by The New York Eye & Ear Infirmary.
NCT00570726 is a Phase 1 study that has completed, run by The New York Eye & Ear Infirmary. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00570726, a Phase 1 study, has completed, sponsored by The New York Eye & Ear Infirmary.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study was designed to evaluate the efficacy and safety in the use of Ranibizumab, an effective vascular endothelial growth factor (VGEF) inhibitor, in treating patients with a failing bleb, characterized by increased fibrosis and vascularization of the conjuctiva, following trabeculectomy. Six subjects from one site will be enrolled in this study.
Interventions
- DRUG Ranibizumab (Lucentis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2000-06 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
What the finished NCT00570726 record still lists
NCT00570726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Ranibizumab (Lucentis) is the first listed.
NCT00570726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00570726 about?
NCT00570726 is a clinical study titled "Treatment of Failing Blebs With Ranibizumab". This study was designed to evaluate the efficacy and safety in the use of Ranibizumab, an effective vascular endothelial growth factor (VGEF) inhibitor, in treating patients with a failing bleb, characterized by increased fibrosis and vascularization of the conjuctiva, following trabeculectomy. Six ...
What is the current status of trial NCT00570726?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2000-06. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00570726?
The interventions under investigation include: Ranibizumab (Lucentis) (DRUG).
Who is sponsoring clinical trial NCT00570726?
This trial is sponsored by The New York Eye & Ear Infirmary, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00570726's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia